GOLDMAN SACHS GROUP INC - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 60 filers reported holding MARKER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$32,000
-56.8%
33,822
-23.2%
0.00%
Q3 2021$74,000
-80.5%
44,055
-67.7%
0.00%
Q2 2021$380,000
+578.6%
136,241
+442.8%
0.00%
Q1 2021$56,000
+40.0%
25,100
-9.0%
0.00%
Q4 2020$40,000
-37.5%
27,594
-35.8%
0.00%
Q3 2020$64,000
-45.8%
42,970
-24.6%
0.00%
Q2 2020$118,000
-4.8%
57,015
+31.8%
0.00%
Q4 2019$124,000
+67.6%
43,253
+197.8%
0.00%
Q3 2019$74,000
-84.4%
14,526
-79.8%
0.00%
Q1 2019$474,00071,7490.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders